Authors’ contributions
-The conception or design of the work: MHS,ARO,EF
-The acquisition, analysis: NG, EF
OR interpretation of data:EF,NG
Drafted the work or substantively revised: EF, AHK, SH, MHS,
All authors have read and approved the manuscript
Reference:
1. Hernández B, Reilly RB, Kenny RA. Investigation of multimorbidity and prevalent disease combinations in older Irish adults using network analysis and association rules.Scientific Report. 2019;9(1):1-12.
2. Violan C, Foguet-Boreu Q, Flores-Mateo G, et al. Prevalence, determinants and patterns of multimorbidity in primary care: a systematic review of observational studies. PloS One. 2014;9(7):e102149.
3. Licher S, Heshmatollah A, van der Willik KD, et al. Lifetime risk and multimorbidity of non-communicable diseases and disease-free life expectancy in the general population: a population-based cohort study. PLoS Med. 2019;16(2):e1002741.
4. Timmermans EJ, Hoogendijk EO, Broese van Groenou MI, et al. Trends across 20 years in multiple indicators of functioning among older adults in the Netherlands.Eur J Public Health. 2019;29(6):1096-1102.
5. Jani BD, Hanlon P, Nicholl BI, et al. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort. BMC Med.2019;17(1):74.
6. Volaklis KA, Thorand B, Peters A, et al. Physical activity, muscular strength, and polypharmacy among older multimorbid persons: Results from the KORA‐Age study. Scand J Med Scien Sport. 2018;28(2):604-612.
7. Villén N, Guisado-Clavero M, Fernández-Bertolín S, et al. Multimorbidity patterns, polypharmacy and their association with liver and kidney abnormalities in people over 65 years of age: a longitudinal study. BMC Geriatr 2020;20(1):1-13.
8. Yu T, Ter Riet G, Puhan MA, Frei A. Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study. NPJ Primary Care Respirat Med. 2017;27(1):1-6.
9. Marques A, Santos DA, Peralta M, Sardinha LB, Valeiro MG. Regular physical activity eliminates the harmful association of television watching with multimorbidity. A cross-sectional study from the European Social Survey. Prev Med.2018;109:28-33.
10. Wang S, Li B, Wu Y, et al. Relationship of sleep duration with sociodemographic characteristics, lifestyle, mental health, and chronic diseases in a large Chinese adult population. J Clin Sleep Med. 2017;13(3):377-384.
11. Griffith LE, Gilsing A, Mangin D, et al. Multimorbidity Frameworks Impact Prevalence and Relationships with Patient‐Important Outcomes. J Am Geriatr Society.2019;67(8):1632-1640.
12. Blümel JE, Carrillo-Larco RM, Vallejo MS, Chedraui P. Multimorbidity in a cohort of middle-aged women: Risk factors and disease clustering. Maturitas. 2020.
13. Eyowas FA, Schneider M, Yirdaw BA, Getahun FA. Multimorbidity of chronic non-communicable diseases and its models of care in low-and middle-income countries: a scoping review protocol. BMJ Open. 2019;9(10):e033320.
14. Poustchi H, Eghtesad S, Kamangar F, et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): rationale, objectives, and design. Am J Epidemiol 2018;187(4):647-655.
15. Farhang S, Faramarzi E, Amini Sani N, et al. Cohort Profile: The AZAR cohort, a health-oriented research model in areas of major environmental change in Central Asia.Inter J Epidemiol. 2019;48(2):382-382h.
16. Medeiros RA. Including Auxiliary Variables in Models with Missing Data Using Full Information Maximum Likelihood. Paper presented at: 2013 Stata Conference2013.
17. Kline RB. Principles And Practice Of Structural Equation Modeling. Guilford publications; 2015.
18. Ahmadi B, Alimohammadian M, Yaseri M, et al. Multimorbidity: epidemiology and risk factors in the Golestan cohort study, Iran: a cross-sectional analysis. Med.2016;95(7).
19. Ebrahimoghli R, Janati A, Sadeghi‐Bazargani H, et al. Epidemiology of multimorbidity in Iran: An investigation of a large pharmacy claims database.Pharmacoepidemiol Drug Safety. 2020;29(1):39-47.
20. Aminisani N, Rastgou L, Shamshirgaran SM, Sarbakhsh P, Ghaderi S, Hyde M. Predictors of multimorbidity among the Kurdish population living in the Northwest of Iran. BMC Public Health. 2020;20(1):1-8.
21. Aoki T, Yamamoto Y, Ikenoue T, Onishi Y, Fukuhara S. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population. Scientific Report. 2018;8(1):1-8.
22. Christofoletti M, Duca GFD, Umpierre D, Malta DC. Chronic noncommunicable diseases multimorbidity and its association with physical activity and television time in a representative Brazilian population. Cadernos De Saude Publica.2019;35:e00016319.
23. Ioakeim-Skoufa I, Poblador-Plou B, Carmona-Pírez J, et al. Multimorbidity Patterns in the General Population: Results from the EpiChron Cohort Study. Inter J Environmental Res Public Health. 2020;17(12):4242.
24. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: A systematic review and meta-analysis. J Affective Disorder. 2017;221:36-46.
25. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness.Dialogues Clin Neuroscien. 2011;13(1):7.
26. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatr 2003;54(3):216-226.
27. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review.Arch Inter Med 2003;163(20):2433-2445.
28. Ziarko M, Mojs E, Piasecki B, Samborski W. The mediating role of dysfunctional coping in the relationship between beliefs about the disease and the level of depression in patients with rheumatoid arthritis. Scientific World J. 2014;2014.
29. Alexopoulos GS, Raue PJ, Sirey JA, Arean PA. Developing an intervention for depressed, chronically medically ill elders: a model from COPD. Inter J GeriatriPsychiat. 2008;23(5):447-453.
30. Penninx BW. Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms. Neuroscien BiobehaviorRev. 2017;74:277-286.
31. Boutayeb A, Boutayeb S, Boutayeb W. Multi-morbidity of non communicable diseases and equity in WHO Eastern Mediterranean countries. Inter J Equity Health.2013;12(1):1-13.
32. Excoffier S, Herzig L, N’Goran AA, Déruaz-Luyet A, Haller DM. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance System (Sentinella). BMJ Open. 2018;8(3):e019616.
33. Nicholson K, Rodrigues R, Anderson KK, Wilk P, Guaiana G, Stranges S. Sleep behaviours and multimorbidity occurrence in middle-aged and older adults: findings from the Canadian Longitudinal Study on Aging (CLSA). Sleep Med.2020;75:156-162.
34. Johnson-Lawrence V, Zajacova A, Sneed R. Education, race/ethnicity, and multimorbidity among adults aged 30–64 in the National Health Interview Survey. SSM - Population Health. 2017;3:366-372.
35. Ross CE, Wu C-l. The links between education and health. Am Sociological Rev. 1995:719-745.
36. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43.
37. Islami F, Pourshams A, Vedanthan R, et al. Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran. Heart. 2013;99(4):272-278.
38. Chung RY, Mercer S, Lai FT, Yip BH, Wong MC, Wong SY. Socioeconomic determinants of multimorbidity: a population-based household survey of Hong Kong Chinese. PLoS One.2015;10(10):e0140040.
39. Ruiz-Castell M, Makovski TT, Bocquet V, Stranges S. Sleep duration and multimorbidity in Luxembourg: results from the European Health Examination Survey in Luxembourg, 2013–2015. BMJ Open. 2019;9(8):e026942.
40. He Q, Sun H, Wu X, et al. Sleep duration and risk of stroke: a dose–response meta-analysis of prospective cohort studies. Sleep Med. 2017;32:66-74.
41. Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T. Self-Reported Sleep Duration and Sleep Disturbance Are Independently Associated with Cortisol Secretion in the Whitehall II Study. J Clin Endocrinol Metabolism.2009;94(12):4801-4809.
42. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabete.2010;59(9):2126-2133.
43. Gangwisch J. Epidemiological evidence for the links between sleep, circadian rhythms and metabolism.Obesity Rev. 2009;10:37-45.
44. Ryan A, Murphy C, Boland F, Galvin R, Smith SM. What Is the Impact of Physical Activity and Physical Function on the Development of Multimorbidity in Older Adults Over Time? A Population-Based Cohort Study. J Gerontol Series A Biol Scien Med Scien. 2018;73(11):1538-1544.